Cash flow Beacon Pharmaceuticals PLC

Equities

BEACONPHAR

BD0482BECON5

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23/06/2025			5-day change	1st Jan Change
102.20 ^BDT	+1.49%		-4.93%	-24.80%

03/02	Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024	CI
2024	Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2024	CI

4b7671b7fe5d0ef5cea217ef275.mnTD6r4Zuu_vr2RXfBGfgzGMXjC6XZpTkdIHTz6oro0.zybusOlw4qChyQckMnbwzF3Eal_2a9Yx8-trGXmY7MvPRJTc0SntpN-CBw

Published financial data: BEACON PHARMACEUTICALS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2020	2021	2022	2023	2024
Revenues	559.08Cr	712.12Cr	802.27Cr	850.99Cr	1.07TCr
Total Revenues	559.08Cr	712.12Cr	802.27Cr	850.99Cr	1.07TCr
Cost of Goods Sold, Total	272.4Cr	345.24Cr	390.63Cr	425.08Cr	521.48Cr
Gross Profit	286.68Cr	366.87Cr	411.65Cr	425.92Cr	548.69Cr
Selling General & Admin Expenses, Total	253.33Cr	230.7Cr	249.92Cr	329.15Cr	367.24Cr
Other Operating Expenses	-	-	-	-	-1.39Cr
Other Operating Expenses, Total	253.33Cr	230.7Cr	249.92Cr	329.15Cr	365.86Cr
Operating Income	33Cr	136.17Cr	161.73Cr	97Cr	182.83Cr
Interest Expense, Total	-15Cr	-16Cr	-34Cr	-46Cr	-100.27Cr
Interest And Investment Income	13.07L	32.44L	3L	36.5L	23Cr
Net Interest Expenses	-15Cr	-16Cr	-34Cr	-46Cr	-77Cr
Currency Exchange Gains (Loss)	-	-	5L	26.78L	-9.37Cr
Other Non Operating Income (Expenses)	-9L	-19.78L	98.05L	15Cr	-
EBT, Excl. Unusual Items	18Cr	119.82Cr	128.99Cr	66Cr	96Cr
Gain (Loss) On Sale Of Investments	-	-	-	1.69Cr	-
Gain (Loss) On Sale Of Assets	-	-	30.39L	30.66L	-65.01L
EBT, Incl. Unusual Items	18Cr	119.82Cr	129.3Cr	68Cr	95Cr
Income Tax Expense	-20Cr	33Cr	36Cr	17Cr	43Cr
Earnings From Continuing Operations	38Cr	86Cr	94Cr	51Cr	52Cr
Net Income to Company	38Cr	86Cr	94Cr	51Cr	52Cr
Net Income - (IS)	38Cr	86Cr	94Cr	51Cr	52Cr
Net Income to Common Incl Extra Items	38Cr	86Cr	94Cr	51Cr	52Cr
Net Income to Common Excl. Extra Items	38Cr	86Cr	94Cr	51Cr	52Cr
Per Share Items
Net EPS - Basic	1.65	3.74	4.05	2.21	2.26
Basic EPS - Continuing Operations	1.65	3.74	4.05	2.21	2.26
Basic Weighted Average Shares Outstanding	23Cr	23Cr	23Cr	23Cr	23Cr
Net EPS - Diluted	1.65	3.74	4.05	2.21	2.26
Diluted EPS - Continuing Operations	1.65	3.74	4.05	2.21	2.26
Diluted Weighted Average Shares Outstanding	23Cr	23Cr	23Cr	23Cr	23Cr
Normalized Basic EPS	0.5	3.24	3.49	1.78	2.6
Normalized Diluted EPS	0.5	3.24	3.49	1.78	2.6
Dividend Per Share	-	1.5	1.6	1.6	2
Payout Ratio	15.23	6.88	39.95	72.78	70.93
Supplemental Items
EBITDA	84Cr	174.69Cr	205.7Cr	148.66Cr	235.61Cr
EBITA	33Cr	136.17Cr	161.73Cr	97Cr	183.64Cr
EBIT	33Cr	136.17Cr	161.73Cr	97Cr	182.83Cr
EBITDAR	88Cr	179.14Cr	210.13Cr	154.68Cr	241.73Cr
Effective Tax Rate - (Ratio)	-106.33	27.96	27.68	24.92	45.35
Current Domestic Taxes	4.61Cr	27Cr	26Cr	5.58Cr	-
Total Current Taxes	4.61Cr	27Cr	26Cr	5.58Cr	37Cr
Deferred Domestic Taxes	-24Cr	6.54Cr	9.93Cr	11Cr	-
Total Deferred Taxes	-24Cr	6.54Cr	9.93Cr	11Cr	6.31Cr
Normalized Net Income	12Cr	75Cr	81Cr	41Cr	60Cr
Interest on Long-Term Debt	5.56Cr	4.79Cr	4.07Cr	7.37Cr	22Cr
Non-Cash Pension Expense	2.33Cr	2.64Cr	3Cr	4.2Cr	22Cr
Supplemental Operating Expense Items
Advertising Expense	100.38Cr	5.3Cr	6.85Cr	6.9Cr	7.26Cr
Marketing Expenses	-	3.55Cr	27.17L	4.55Cr	-
Selling and Marketing Expenses	221.05Cr	186.06Cr	197.36Cr	258.57Cr	282.35Cr
General and Administrative Expenses	27Cr	34Cr	42Cr	61Cr	74Cr
Research And Development Expense From Footnotes	72.89L	94.28L	1.44Cr	14Cr	6.96Cr
Net Rental Expense, Total	4.04Cr	4.46Cr	4.43Cr	6.02Cr	6.12Cr
Imputed Operating Lease Interest Expense	2.43Cr	2.51Cr	3.79Cr	3.94Cr	5.52Cr
Imputed Operating Lease Depreciation	1.6Cr	1.95Cr	64.27L	2.09Cr	59.58L
Maintenance & Repair Expenses, Total	5.39Cr	14Cr	21Cr	20Cr	13Cr

Fiscal Period: June	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	60Cr	34Cr	54Cr	45Cr	31Cr
Short Term Investments	1.47Cr	58.72L	61.58L	2.53Cr	1.54Cr
Total Cash And Short Term Investments	61Cr	34Cr	54Cr	48Cr	32Cr
Accounts Receivable, Total	105.96Cr	193.34Cr	196.41Cr	221.51Cr	275.79Cr
Other Receivables	17Cr	-	-	-	22Cr
Notes Receivable	-	40Cr	52Cr	273.2Cr	262.71Cr
Total Receivables	122.86Cr	233.71Cr	248.64Cr	494.72Cr	560.98Cr
Inventory	103.26Cr	127.87Cr	197.19Cr	199.17Cr	288.76Cr
Deferred Tax Assets Current	31Cr	24Cr	14Cr	-	-
Other Current Assets, Total	61Cr	101.63Cr	130.06Cr	156.59Cr	389.72Cr
Total Current Assets	378.56Cr	521.58Cr	644.42Cr	898.21Cr	1.27TCr
Gross Property Plant And Equipment	415.69Cr	444.68Cr	593.19Cr	772.8Cr	874.64Cr
Accumulated Depreciation	-77Cr	-112.79Cr	-156.13Cr	-206.91Cr	-255.97Cr
Net Property Plant And Equipment	339.06Cr	331.89Cr	437.07Cr	565.89Cr	618.67Cr
Long-term Investments	6L	9L	10.26L	10.61L	-
Other Intangibles, Total	-	-	-	-	2.8Cr
Other Long-Term Assets, Total	-	2	-	-	-
Total Assets	717.69Cr	853.56Cr	1.08TCr	1.46TCr	1.89TCr
Liabilities
Accounts Payable, Total	-2.71Cr	11Cr	11Cr	18Cr	91Cr
Accrued Expenses, Total	23Cr	35Cr	43Cr	68Cr	31Cr
Short-term Borrowings	153.45Cr	188.36Cr	341.31Cr	650.03Cr	669.89Cr
Current Portion of Long-Term Debt	15Cr	23Cr	22Cr	18Cr	89Cr
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	-	-1.86Cr	26Cr	5.58Cr	25Cr
Unearned Revenue Current, Total	-	-	-	-	-
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	16Cr	23Cr	24Cr	22Cr	21Cr
Total Current Liabilities	205.35Cr	279.27Cr	467.41Cr	781.42Cr	926.2Cr
Long-Term Debt	49Cr	39Cr	20Cr	77Cr	272.89Cr
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	-	67Cr
Deferred Tax Liability Non Current	-	-	-	11Cr	18Cr
Total Liabilities	254.66Cr	318.04Cr	487.2Cr	870.01Cr	1.28TCr
Common Stock, Total	231Cr	231Cr	231Cr	231Cr	231Cr
Retained Earnings	74Cr	163.87Cr	240.44Cr	256.55Cr	289.18Cr
Comprehensive Income and Other	158.16Cr	140.65Cr	122.94Cr	106.66Cr	89Cr
Total Common Equity	463.03Cr	535.52Cr	594.39Cr	594.2Cr	609.04Cr
Total Equity	463.03Cr	535.52Cr	594.39Cr	594.2Cr	609.04Cr
Total Liabilities And Equity	717.69Cr	853.56Cr	1.08TCr	1.46TCr	1.89TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	23Cr	23Cr	23Cr	23Cr	23Cr
ECS Total Common Shares Outstanding	23Cr	23Cr	23Cr	23Cr	23Cr
Book Value / Share	20.04	23.18	25.73	25.72	26.37
Tangible Book Value	463.03Cr	535.52Cr	594.39Cr	594.2Cr	606.24Cr
Tangible Book Value Per Share	20.04	23.18	25.73	25.72	26.24
Total Debt	218.14Cr	249.72Cr	382.7Cr	745.53Cr	1.03TCr
Net Debt	156.8Cr	215.35Cr	328.23Cr	697.78Cr	999.69Cr
Debt Equivalent Oper. Leases	32Cr	36Cr	35Cr	48Cr	49Cr
Account Code - Inventory Valuation	-	6	6	6	6
Inventories - Raw Materials, Total	39Cr	44Cr	92Cr	85Cr	153.31Cr
Inventories - Work In Process, Total	17Cr	26Cr	22Cr	30Cr	32Cr
Inventories - Finished Goods, Total	36Cr	44Cr	74Cr	67Cr	87Cr
Inventories - Others	11Cr	14Cr	8.78Cr	18Cr	16Cr
Land - (BS)	57Cr	57Cr	62Cr	66Cr	66Cr
Buildings, Total	98Cr	98Cr	98Cr	108.31Cr	220.81Cr
Machinery, Total	226.96Cr	246.51Cr	303.09Cr	403.02Cr	474.45Cr
Full Time Employees	-	3.53T	3.53T	3.87T	4.16T

Fiscal Period: June	2020	2021	2022	2023	2024
Net Income	38Cr	86Cr	94Cr	51Cr	52Cr
Depreciation & Amortization - CF	51Cr	39Cr	44Cr	52Cr	52Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	80.29L
Depreciation & Amortization, Total	51Cr	39Cr	44Cr	52Cr	53Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	65.01L
Other Operating Activities, Total	-24Cr	7.59Cr	44Cr	40Cr	29Cr
Change In Accounts Receivable	-36Cr	-87Cr	-3.07Cr	-25Cr	-77Cr
Change In Inventories	-2.83Cr	-25Cr	-69Cr	-1.97Cr	-90Cr
Change In Accounts Payable	-85.81L	18Cr	-78.29L	15Cr	68Cr
Change In Income Taxes	-6.49Cr	16Cr	-17Cr	-55Cr	-
Change in Other Net Operating Assets	10Cr	-35Cr	17Cr	-14Cr	-54Cr
Cash from Operations	29Cr	20Cr	108.22Cr	62Cr	-18Cr
Capital Expenditure	-31Cr	-31Cr	-171.92Cr	-181.43Cr	-109.5Cr
Sale of Property, Plant, and Equipment	-	-	-	-	3.01Cr
Sale (Purchase) of Intangible assets	-	-	-	-	-2.52Cr
Investment in Marketable and Equity Securities, Total	-8L	-40Cr	-12Cr	-219.02Cr	-127.62Cr
Other Investing Activities, Total	13.07L	32.44L	-	3.98Cr	-1
Cash from Investing	-31Cr	-71Cr	-183.78Cr	-396.48Cr	-236.63Cr
Short Term Debt Issued, Total	47Cr	35Cr	152.95Cr	308.72Cr	-
Long-Term Debt Issued, Total	-	-	-	54Cr	286.39Cr
Total Debt Issued	47Cr	35Cr	152.95Cr	362.83Cr	286.39Cr
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-7.67Cr	-3.33Cr	-20Cr	-	-
Total Debt Repaid	-7.67Cr	-3.33Cr	-20Cr	-	-
Common Dividends Paid	-5.8Cr	-5.94Cr	-37Cr	-37Cr	-37Cr
Common & Preferred Stock Dividends Paid	-5.8Cr	-5.94Cr	-37Cr	-37Cr	-37Cr
Other Financing Activities, Total	-	-	-1	-	-
Cash from Financing	34Cr	26Cr	96Cr	325.73Cr	249.44Cr
Foreign Exchange Rate Adjustments	-	-	-	-	-9.37Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	32Cr	-26Cr	20Cr	-8.63Cr	-15Cr
Supplemental Items
Cash Interest Paid	15Cr	17Cr	34Cr	46Cr	98Cr
Cash Income Tax Paid (Refund)	2Cr	1.73Cr	45Cr	27Cr	26Cr
Levered Free Cash Flow	-23Cr	-56Cr	-114.56Cr	-349.75Cr	-310.21Cr
Unlevered Free Cash Flow	-14Cr	-46Cr	-93Cr	-320.95Cr	-247.54Cr
Change In Net Working Capital	54Cr	138.18Cr	67Cr	251.89Cr	302.56Cr
Net Debt Issued / Repaid	40Cr	32Cr	132.98Cr	362.83Cr	286.39Cr

Fiscal Period: June	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.46	10.83	10.45	4.75	6.81
Return on Total Capital	3.6	11.61	11.47	5.22	7.67
Return On Equity %	10.01	17.29	16.55	8.58	8.66
Return on Common Equity	10.01	17.29	16.55	8.58	8.66
Margin Analysis
Gross Profit Margin %	51.28	51.52	51.31	50.05	51.27
SG&A Margin	45.31	32.4	31.15	38.68	34.32
EBITDA Margin %	15.1	24.53	25.64	17.47	22.02
EBITA Margin %	5.96	19.12	20.16	11.37	17.16
EBIT Margin %	5.96	19.12	20.16	11.37	17.08
Income From Continuing Operations Margin %	6.81	12.12	11.65	5.99	4.87
Net Income Margin %	6.81	12.12	11.65	5.99	4.87
Net Avail. For Common Margin %	6.81	12.12	11.65	5.99	4.87
Normalized Net Income Margin	2.06	10.52	10.05	4.84	5.61
Levered Free Cash Flow Margin	-4.11	-7.89	-14.28	-41.1	-28.99
Unlevered Free Cash Flow Margin	-2.44	-6.45	-11.65	-37.71	-23.13
Asset Turnover
Asset Turnover	0.93	0.91	0.83	0.67	0.64
Fixed Assets Turnover	2	2.12	2.09	1.7	1.81
Receivables Turnover (Average Receivables)	6.35	4.76	4.12	4.07	4.42
Inventory Turnover (Average Inventory)	2.67	2.99	2.4	2.14	2.14
Short Term Liquidity
Current Ratio	1.84	1.87	1.38	1.15	1.37
Quick Ratio	0.9	0.82	0.54	0.34	0.36
Operating Cash Flow to Current Liabilities	0.14	0.07	0.23	0.08	-0.02
Days Sales Outstanding (Average Receivables)	57.68	76.7	88.66	89.63	82.74
Days Outstanding Inventory (Average Inventory)	136.83	122.18	151.87	170.17	171.23
Average Days Payable Outstanding	0.18	4.27	8.97	8.91	36.03
Cash Conversion Cycle (Average Days)	194.33	194.61	231.56	250.88	217.94
Long Term Solvency
Total Debt/Equity	47.11	46.63	64.39	125.47	169.43
Total Debt / Total Capital	32.02	31.8	39.17	55.65	62.89
LT Debt/Equity	10.65	7.24	3.33	13	44.81
Long-Term Debt / Total Capital	7.24	4.94	2.03	5.77	16.63
Total Liabilities / Total Assets	35.48	37.26	45.05	59.42	67.83
EBIT / Interest Expense	2.23	8.26	4.79	2.1	1.82
EBITDA / Interest Expense	5.66	10.6	6.09	3.23	2.35
(EBITDA - Capex) / Interest Expense	3.55	8.7	1	-0.71	1.26
Total Debt / EBITDA	2.58	1.43	1.86	5.01	4.38
Net Debt / EBITDA	1.86	1.23	1.6	4.69	4.24
Total Debt / (EBITDA - Capex)	4.11	1.74	11.33	-22.75	8.18
Net Debt / (EBITDA - Capex)	2.96	1.5	9.72	-21.29	7.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.31	27.37	12.66	6.07	25.76
Gross Profit, 1 Yr. Growth %	26.12	27.97	12.2	3.47	28.83
EBITDA, 1 Yr. Growth %	-2.19	106.86	17.75	-27.73	57.28
EBITA, 1 Yr. Growth %	6.05	308.35	18.77	-40.16	86.79
EBIT, 1 Yr. Growth %	6.05	308.35	18.77	-40.16	86.73
Earnings From Cont. Operations, 1 Yr. Growth %	223.44	126.74	8.33	-45.47	2.19
Net Income, 1 Yr. Growth %	223.44	126.74	8.33	-45.47	2.19
Normalized Net Income, 1 Yr. Growth %	12.91	549.4	7.66	-48.91	41.98
Diluted EPS Before Extra, 1 Yr. Growth %	223.44	126.74	8.33	-45.47	2.19
Accounts Receivable, 1 Yr. Growth %	50.85	82.46	1.59	12.78	32.56
Inventory, 1 Yr. Growth %	2.82	23.83	54.22	1	44.99
Net Property, Plant and Equip., 1 Yr. Growth %	54.03	-2.12	31.69	29.47	9.54
Total Assets, 1 Yr. Growth %	47.34	18.93	26.72	35.38	29.3
Tangible Book Value, 1 Yr. Growth %	55.42	15.65	10.99	-0.03	2.21
Common Equity, 1 Yr. Growth %	55.42	15.65	10.99	-0.03	2.5
Cash From Operations, 1 Yr. Growth %	32.08	-32.49	450.56	-42.6	-128.92
Capital Expenditures, 1 Yr. Growth %	28.88	-0.17	448.56	5.53	-39.65
Levered Free Cash Flow, 1 Yr. Growth %	1.27T	144.83	103.83	205.3	-18.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-273.13	236.94	103.56	243.49	-29.8
Dividend Per Share, 1 Yr. Growth %	-	-	6.67	0	25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.93	23.79	19.79	9.32	15.5
Gross Profit, 2 Yr. CAGR %	25.18	27.04	19.83	7.75	15.45
EBITDA, 2 Yr. CAGR %	5.5	42.24	56.07	-7.75	7.03
EBITA, 2 Yr. CAGR %	12.54	108.1	120.22	-15.7	6.56
EBIT, 2 Yr. CAGR %	12.54	108.1	120.22	-15.7	6.33
Earnings From Cont. Operations, 2 Yr. CAGR %	73.75	170.81	56.72	-23.15	-25.35
Net Income, 2 Yr. CAGR %	73.75	170.81	56.72	-23.15	-25.35
Normalized Net Income, 2 Yr. CAGR %	20.99	170.79	164.41	-25.83	-13.74
Diluted EPS Before Extra, 2 Yr. CAGR %	73.75	170.81	56.72	-23.15	-25.35
Accounts Receivable, 2 Yr. CAGR %	55.75	65.9	36.15	7.04	18.5
Inventory, 2 Yr. CAGR %	0.54	12.84	38.19	24.8	21.01
Net Property, Plant and Equip., 2 Yr. CAGR %	16.3	22.79	13.54	30.58	18.98
Total Assets, 2 Yr. CAGR %	20.92	32.38	22.76	30.97	32.3
Tangible Book Value, 2 Yr. CAGR %	24.22	34.07	13.3	5.34	0.99
Common Equity, 2 Yr. CAGR %	24.22	34.07	13.3	5.34	1.23
Cash From Operations, 2 Yr. CAGR %	-1.44	-5.57	92.8	77.77	-59.26
Capital Expenditures, 2 Yr. CAGR %	-1.51	13.43	134.02	140.61	-20.19
Levered Free Cash Flow, 2 Yr. CAGR %	147.51	479.98	123.39	149.46	64.55
Unlevered Free Cash Flow, 2 Yr. CAGR %	68.85	141.52	161.89	164.42	62.76
Dividend Per Share, 2 Yr. CAGR %	-	73.21	-	3.28	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.77	23.72	19.96	15.03	14.54
Gross Profit, 3 Yr. CAGR %	25.17	26.11	21.89	14.11	14.36
EBITDA, 3 Yr. CAGR %	8.76	32.05	33.56	20.75	10.49
EBITA, 3 Yr. CAGR %	8.44	72.93	72.62	42.64	10.48
EBIT, 3 Yr. CAGR %	8.44	72.93	72.62	42.64	10.32
Earnings From Cont. Operations, 3 Yr. CAGR %	54.25	89.87	99.53	10.23	-15.49
Net Income, 3 Yr. CAGR %	54.25	89.87	99.53	10.23	-15.49
Normalized Net Income, 3 Yr. CAGR %	16.76	111.84	99.11	52.87	-7.13
Diluted EPS Before Extra, 3 Yr. CAGR %	54.25	89.87	99.53	10.23	-15.49
Accounts Receivable, 3 Yr. CAGR %	52.53	64.19	40.88	27.86	12.57
Inventory, 3 Yr. CAGR %	-1.74	7.77	25.22	24.48	31.2
Net Property, Plant and Equip., 3 Yr. CAGR %	8.18	9.81	25.69	18.62	23.07
Total Assets, 3 Yr. CAGR %	12.02	20.25	30.46	26.83	30.41
Tangible Book Value, 3 Yr. CAGR %	15.68	21.3	25.89	8.67	4.22
Common Equity, 3 Yr. CAGR %	15.68	21.3	25.89	8.67	4.38
Cash From Operations, 3 Yr. CAGR %	-33.29	-13.12	69.96	28.74	-2.96
Capital Expenditures, 3 Yr. CAGR %	-20.46	-1.07	91.82	79.46	51.74
Levered Free Cash Flow, 3 Yr. CAGR %	-8.01	146.61	309.29	147.91	76.72
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.38	112.58	128.14	186.67	75.36
Dividend Per Share, 3 Yr. CAGR %	-	35.72	47.36	-	10.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.19	23.37	22.16	17.74	18.16
Gross Profit, 5 Yr. CAGR %	23.69	25.09	23.01	18.41	19.27
EBITDA, 5 Yr. CAGR %	4.89	21.99	25.66	14.4	22.24
EBITA, 5 Yr. CAGR %	3.38	39.19	43.97	29.73	42.33
EBIT, 5 Yr. CAGR %	3.38	39.19	43.97	29.73	42.2
Earnings From Cont. Operations, 5 Yr. CAGR %	58.09	69.66	55.23	32.23	34.65
Net Income, 5 Yr. CAGR %	58.09	69.66	55.23	32.23	34.65
Normalized Net Income, 5 Yr. CAGR %	29.32	76.55	61.92	39.22	42.49
Diluted EPS Before Extra, 5 Yr. CAGR %	58.09	69.66	55.23	32.23	34.65
Accounts Receivable, 5 Yr. CAGR %	28.27	43.03	45.75	38.36	31.46
Inventory, 5 Yr. CAGR %	-3.19	1.47	12.62	14.29	23.52
Net Property, Plant and Equip., 5 Yr. CAGR %	9.26	6.26	10.29	17.69	22.96
Total Assets, 5 Yr. CAGR %	8.66	11.22	16.2	24.43	31.19
Tangible Book Value, 5 Yr. CAGR %	9.76	12.27	14.72	14.64	15.27
Common Equity, 5 Yr. CAGR %	9.76	12.27	14.72	14.64	15.37
Cash From Operations, 5 Yr. CAGR %	35.48	-18.82	1.99	15.69	-4.01
Capital Expenditures, 5 Yr. CAGR %	17.65	-12.49	22.47	41.16	35.07
Levered Free Cash Flow, 5 Yr. CAGR %	23.85	53.34	31.18	147.75	184.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.34	52.96	19.29	131.97	99.32
Dividend Per Share, 5 Yr. CAGR %	-	24.57	26.19	21.67	31.95